Lung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profile

Abstract Bronchiolitis Obliterans Syndrome is the major determinant of the graft function loss after lung transplantation, but its pathogenesis is still incompletely understood and currently available therapeutic strategies are poorly effective. A deeper understanding of its pathogenic mechanisms is...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Serena Vella, Pier Giulio Conaldi, Emanuela Cova, Federica Meloni, Rosa Liotta, Salvatore Cuzzocrea, Lavinia Martino, Alessandro Bertani, Angelo Luca, Patrizio Vitulo
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/42b1010b154e4e2f804bbd54ef3d9cd0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:42b1010b154e4e2f804bbd54ef3d9cd0
record_format dspace
spelling oai:doaj.org-article:42b1010b154e4e2f804bbd54ef3d9cd02021-12-02T15:08:50ZLung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profile10.1038/s41598-018-29504-52045-2322https://doaj.org/article/42b1010b154e4e2f804bbd54ef3d9cd02018-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-29504-5https://doaj.org/toc/2045-2322Abstract Bronchiolitis Obliterans Syndrome is the major determinant of the graft function loss after lung transplantation, but its pathogenesis is still incompletely understood and currently available therapeutic strategies are poorly effective. A deeper understanding of its pathogenic mechanisms is crucial for the development of new strategies to prevent and treat this devastating complication. In this study, we focused on the mesenchymal stromal cells, recently recognized as BOS key effectors, and our primary aim was to identify their epigenetic determinants, such as histone modifications and non-coding RNA regulation, which could contribute to their differentiation in myofibroblasts. Interestingly, we identified a deregulated expression of histone deacetylases and methyltransferases, and a microRNA-epigenetic regulatory network, which could represent novel targets for anti-fibrotic therapy. We validated our results in vitro, in a cell model of fibrogenesis, confirming the epigenetic involvement in this process and paving the way for a new application for epigenetic drugs.Serena VellaPier Giulio ConaldiEmanuela CovaFederica MeloniRosa LiottaSalvatore CuzzocreaLavinia MartinoAlessandro BertaniAngelo LucaPatrizio VituloNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Serena Vella
Pier Giulio Conaldi
Emanuela Cova
Federica Meloni
Rosa Liotta
Salvatore Cuzzocrea
Lavinia Martino
Alessandro Bertani
Angelo Luca
Patrizio Vitulo
Lung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profile
description Abstract Bronchiolitis Obliterans Syndrome is the major determinant of the graft function loss after lung transplantation, but its pathogenesis is still incompletely understood and currently available therapeutic strategies are poorly effective. A deeper understanding of its pathogenic mechanisms is crucial for the development of new strategies to prevent and treat this devastating complication. In this study, we focused on the mesenchymal stromal cells, recently recognized as BOS key effectors, and our primary aim was to identify their epigenetic determinants, such as histone modifications and non-coding RNA regulation, which could contribute to their differentiation in myofibroblasts. Interestingly, we identified a deregulated expression of histone deacetylases and methyltransferases, and a microRNA-epigenetic regulatory network, which could represent novel targets for anti-fibrotic therapy. We validated our results in vitro, in a cell model of fibrogenesis, confirming the epigenetic involvement in this process and paving the way for a new application for epigenetic drugs.
format article
author Serena Vella
Pier Giulio Conaldi
Emanuela Cova
Federica Meloni
Rosa Liotta
Salvatore Cuzzocrea
Lavinia Martino
Alessandro Bertani
Angelo Luca
Patrizio Vitulo
author_facet Serena Vella
Pier Giulio Conaldi
Emanuela Cova
Federica Meloni
Rosa Liotta
Salvatore Cuzzocrea
Lavinia Martino
Alessandro Bertani
Angelo Luca
Patrizio Vitulo
author_sort Serena Vella
title Lung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profile
title_short Lung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profile
title_full Lung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profile
title_fullStr Lung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profile
title_full_unstemmed Lung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profile
title_sort lung resident mesenchymal cells isolated from patients with the bronchiolitis obliterans syndrome display a deregulated epigenetic profile
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/42b1010b154e4e2f804bbd54ef3d9cd0
work_keys_str_mv AT serenavella lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile
AT piergiulioconaldi lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile
AT emanuelacova lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile
AT federicameloni lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile
AT rosaliotta lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile
AT salvatorecuzzocrea lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile
AT laviniamartino lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile
AT alessandrobertani lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile
AT angeloluca lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile
AT patriziovitulo lungresidentmesenchymalcellsisolatedfrompatientswiththebronchiolitisobliteranssyndromedisplayaderegulatedepigeneticprofile
_version_ 1718387993534791680